WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles:
Related suggestion:
Online city tours entertain journalists home and abroad at Beijing 2022Travel rush has arrived as millions on the moveInnovative greening manifests China's environmental preservation driveHyderabad racks IPL record total of 287China, Greece sign deal to boost tourism cooperationChina aims to build world's largest national park systemUpcoming Met Gala exhibit aims to be a multiJenna Bush Hager admits she LOST one of her eightCambodia deports 130 online scam suspects to China — Radio Free AsiaBautista Agut earns 399th tour
2.5402s , 6500.15625 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,Worldly Web news portal